Influence of cytokines on HIV-specific antibody-dependent cellular cytotoxicity activation profile of natural killer cells

PLoS ONE

Volumn 7, Issue 6, 2012, Pages

  Wren, Leia ^a   Parsons, Matthew S ^a,b   Isitman, Gamze ^a   Center, Robert J ^a   Kelleher, Anthony D ^c   Stratov, Ivan ^a,d   Bernard, Nicole F ^b   Kent, Stephen J ^a,d  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b MCGILL UNIVERSITY   (Canada)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

^d Sexual Health Physician at Melbourne Sexual Health Clinic   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; IMMUNOGLOBULIN G; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 15; INTERLEUKIN 4; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 3DL1; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 1; VIRUS ENVELOPE PROTEIN; HLA B ANTIGEN; HLA BW4 ANTIGEN; HLA-BW4 ANTIGEN; KIR3DL1 PROTEIN, HUMAN;

ADULT; AGED; ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY; ANTIGEN EXPRESSION; ARTICLE; CD4 LYMPHOCYTE COUNT; CELL ACTIVATION; CLINICAL ARTICLE; CONTROLLED STUDY; DEGRANULATION; EFFECTOR CELL; FEMALE; HOMOZYGOSITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; INTERFERON PRODUCTION; MALE; NATURAL KILLER CELL; PROTEIN EXPRESSION; VIRUS LOAD; AUSTRALIA; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOLOGY; METABOLISM; NONPARAMETRIC TEST;

ANTIBODY-DEPENDENT CELL CYTOTOXICITY; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; HIV ANTIBODIES; HIV INFECTIONS; HLA-B ANTIGENS; HUMANS; INTERLEUKIN-10; INTERLEUKIN-15; KILLER CELLS, NATURAL; NEW SOUTH WALES; RECEPTORS, KIR3DL1; STATISTICS, NONPARAMETRIC;

EID: 84862195016     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0038580     Document Type: Article

References (57)

1. Walker BD, Burton DR, (2008) Toward an AIDS vaccine. Science 320: 760 764.
2. Rerks-Ngarm S, Pitisuttithum P, Nitayaphan S, Kaewkungwal J, Chiu J, (2009) Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand. N Engl J Med 361: 2209 2220.
3. Wren L, Kent SJ, (2011) HIV Vaccine efficacy trial: glimmers of hope and the potential role of antibody-dependent cellular cytotoxicity. Hum Vaccin 7: 466 473.
4. Karnasuta C, Paris RM, Cox JH, Nitayaphan S, Pitisuttithum P, (2005) Antibody-dependent cell-mediated cytotoxic responses in participants enrolled in a phase I/II ALVAC-HIV/AIDSVAX B/E prime-boost HIV-1 vaccine trial in Thailand. Vaccine 23: 2522 2529.
5. Hessell AJ, Hangartner L, Hunter M, Havenith CE, Beurskens FJ, (2007) Fc receptor but not complement binding is important in antibody protection against HIV. Nature 449: 101 104.
6. Sun Y, Asmal M, Lane S, Permar SR, Schmidt SD, Mascola JR, (2011) Antibody-dependent cell-mediated cytotoxicity in simian immunodeficiency virus-infected rhesus monkeys. J Virol 85: 6906 6912.
7. Baum LL, Cassutt KJ, Knigge K, Khattri R, Margolick J, (1996) HIV-1 gp120-specific antibody-dependent cell-mediated cytotoxicity correlates with rate of disease progression. J Immunol 157: 2168 2173.
8. Scott-Algara D, Truong LX, Versmisse P, David A, Luong TT, (2003) Cutting edge: increased NK cell activity in HIV-1-exposed but uninfected Vietnamese intravascular drug users. J Immunol 171: 5663 5667.
9. Lambotte O, Ferrari G, Moog C, Yates NL, Liao HX, (2009) Heterogeneous neutralizing antibody and antibody-dependent cell cytotoxicity responses in HIV-1 elite controllers. AIDS 23: 897 906.
10. Brocca-Cofano E, McKinnon K, Demberg T, Venzon D, Hidajat R, (2011) Vaccine-elicited SIV and HIV envelope-specific IgA and IgG memory B cells in rhesus macaque peripheral blood correlate with functional antibody responses and reduced viremia. Vaccine 29: 3310 3319.
11. Patel D, Guo X, Ng S, Melchior M, Balderes P, (2010) IgG isotype, glycosylation, and EGFR expression determine the induction of antibody-dependent cellular cytotoxicity in vitro by cetuximab. Hum Antibodies 19: 89 99.
12. Chung AW, Isitman G, Navis M, Kramski M, Center RJ, et al (2011) Immune escape from HIV-specific antibody-dependent cellular cytotoxicity (ADCC) pressure. Proc Natl Acad Sci U S A 108: 7505 7510.
13. Parsons MS, Zipperlen K, Gallant M, Grant M, (2010) Killer cell immunoglobulin-like receptor 3DL1 licenses CD16-mediated effector functions of natural killer cells. J Leukoc Biol 88: 905 912.
14. Anfossi N, Andre P, Guia S, Falk CS, Roetynck S, (2006) Human NK cell education by inhibitory receptors for MHC class I. Immunity 25: 331 342.
15. Parsons MS, Wren L, Isitman G, Navis M, Stratov I, (2012) HIV infection abrogates the functional advantage of natural killer cells educated through KIR3DL1/HLA-Bw4 interactions to mediate anti-HIV antibody-dependent cellular cytotoxicity. J Virol.
16. Iannello A, Debbeche O, Samarani S, Ahmad A, (2008) Antiviral NK cell responses in HIV infection: II. viral strategies for evasion and lessons for immunotherapy and vaccination. J Leukoc Biol 84: 27 49.
17. Roberts L, Passmore JA, Williamson C, Little F, Bebell LM, (2010) Plasma cytokine levels during acute HIV-1 infection predict HIV disease progression. AIDS 24: 819 831.
18. Navikas V, Link J, Wahren B, Persson C, Link H, (1994) Increased levels of interferon-gamma (IFN-gamma), IL-4 and transforming growth factor-beta (TGF-beta) mRNA expressing blood mononuclear cells in human HIV infection. Clin Exp Immunol 96: 59 63.
19. Brockman MA, Kwon DS, Tighe DP, Pavlik DF, Rosato PC, (2009) IL-10 is up-regulated in multiple cell types during viremic HIV infection and reversibly inhibits virus-specific T cells. Blood 114: 346 356.
20. Srikanth P, Castillo RC, Sridharan G, John TJ, Zachariah A, (2000) Increase in plasma IL-10 levels and rapid loss of CD4+ T cells among HIV-infected individuals in south India. Int J STD AIDS 11: 49 51.
21. Napolitano LA, Grant RM, Deeks SG, Schmidt D, De Rosa SC, (2001) Increased production of IL-7 accompanies HIV-1-mediated T-cell depletion: implications for T-cell homeostasis. Nat Med 7: 73 79.
22. Hober D, Ajana F, Petit MC, Sartiaux C, Boniface M, (1993) Granulocyte-macrophage colony-stimulating factor and tumor necrosis factor alpha in patients with human immunodeficiency virus (HIV) type 1 infection. Microbiol Immunol 37: 785 792.
23. Rautonen J, Rautonen N, Martin NL, Philip R, Wara DW, (1991) Serum interleukin-6 concentrations are elevated and associated with elevated tumor necrosis factor-alpha and immunoglobulin G and A concentrations in children with HIV infection. AIDS 5: 1319 1325.
24. D'Ettorre G, Forcina G, Lichtner M, Mengoni F, D'Agostino C, (2002) Interleukin-15 in HIV infection: immunological and virological interactions in antiretroviral-naive and-treated patients. AIDS 16: 181 188.
25. Marshall JD, Chehimi J, Gri G, Kostman JR, Montaner LJ, (1999) The interleukin-12-mediated pathway of immune events is dysfunctional in human immunodeficiency virus-infected individuals. Blood 94: 1003 1011.
26. Gregson JN, Steel A, Bower M, Gazzard BG, Gotch FM, (2009) Elevated plasma lipopolysaccharide is not sufficient to drive natural killer cell activation in HIV-1-infected individuals. AIDS 23: 29 34.
27. Douek D, (2007) HIV disease progression: immune activation, microbes, and a leaky gut. Top HIV Med 15: 114 117.
28. Hoglund P, Brodin P, (2010) Current perspectives of natural killer cell education by MHC class I molecules. Nat Rev Immunol 10: 724 734.
29. Stratov I, Chung A, Kent SJ, (2008) Robust NK cell-mediated human immunodeficiency virus (HIV)-specific antibody-dependent responses in HIV-infected subjects. J Virol 82: 5450 5459.
30. Chung AW, Rollman E, Center RJ, Kent SJ, Stratov I (2009) Rapid degranulation of NK cells following activation by HIV-specific antibodies. J Immunol 182: 1202 1210.
31. Center RJ, Wheatley AK, Campbell SM, Gaeguta AJ, Peut V, et al (2009) Induction of HIV-1 subtype B and AE-specific neutralizing antibodies in mice and macaques with DNA prime and recombinant gp140 protein boost regimens. Vaccine 27: 6605 6612.
32. Isitman G, Chung AW, Navis M, Kent SJ, Stratov I, (2011) Pol as a target for antibody dependent cellular cytotoxicity responses in HIV-1 infection. Virology 412: 110 116.
33. Chung AW, Navis M, Isitman G, Wren L, Silvers J, (2011) Activation of NK cells by ADCC antibodies and HIV disease progression. J Acquir Immune Defic Syndr 58: 127 131.
34. Johansson SE, Rollman E, Chung AW, Center RJ, Hejdeman B, et al (2011) NK cell function and antibodies mediating ADCC in HIV-1-infected viremic and controller patients. Viral Immunol 24: 359 368.
35. Thobakgale CF, Streeck H, Mkhwanazi N, Mncube Z, Maphumulo L, (2011) Short Communication: CD8(+) T Cell Polyfunctionality Profiles in Progressive and Nonprogressive Pediatric HIV Type 1 Infection. AIDS Res Hum Retroviruses 27: 1005 1012.
36. Boulet S, Song R, Kamya P, Bruneau J, Shoukry NH, (2010) HIV protective KIR3DL1 and HLA-B genotypes influence NK cell function following stimulation with HLA-devoid cells. J Immunol 184: 2057 2064.
37. Parsons MS, Boulet S, Song R, Bruneau J, Shoukry NH, (2010) Mind the gap: lack of association between KIR3DL1*004/HLA-Bw4-induced natural killer cell function and protection from HIV infection. J Infect Dis 202: S356 S360.
38. Brodin P, Lakshmikanth T, Johansson S, Karre K, Hoglund P, (2009) The strength of inhibitory input during education quantitatively tunes the functional responsiveness of individual natural killer cells. Blood 113: 2434 2441.
39. Juelke K, Killig M, Thiel A, Dong J, Romagnani C, (2009) Education of hyporesponsive NK cells by cytokines. Eur J Immunol 39: 2548 2555.
40. Boulet S, Kleyman M, Kim JY, Kamya P, Sharafi S, (2008) A combined genotype of KIR3DL1 high expressing alleles and HLA-B*57 is associated with a reduced risk of HIV infection. AIDS 22: 1487 1491.
41. Martin MP, Qi Y, Gao X, Yamada E, Martin JN, (2007) Innate partnership of HLA-B and KIR3DL1 subtypes against HIV-1. Nat Genet 39: 733 740.
42. Roda JM, Joshi T, Butchar JP, McAlees JW, Lehman A, (2007) The activation of natural killer cell effector functions by cetuximab-coated, epidermal growth factor receptor positive tumor cells is enhanced by cytokines. Clin Cancer Res 13: 6419 6428.
43. Lin SJ, Roberts RL, Ank BJ, Nguyen QH, Thomas EK, (1998) Effect of interleukin (IL)-12 and IL-15 on activated natural killer (ANK) and antibody-dependent cellular cytotoxicity (ADCC) in HIV infection. J Clin Immunol 18: 335 345.
44. Moga E, Canto E, Vidal S, Juarez C, Sierra J, (2011) Interleukin-15 enhances rituximab-dependent cytotoxicity against chronic lymphocytic leukemia cells and overcomes transforming growth factor beta-mediated immunosuppression. Exp Hematol 39: 1064 1071.
45. Loubeau M, Ahmad A, Toma E, Menezes J, (1997) Enhancement of natural killer and antibody-dependent cytolytic activities of the peripheral blood mononuclear cells of HIV-infected patients by recombinant IL-15. J Acquir Immune Defic Syndr Hum Retrovirol 16: 137 145.
46. Fauriat C, Ivarsson MA, Ljunggren HG, Malmberg KJ, Michaelsson J, (2010) Education of human natural killer cells by activating killer cell immunoglobulin-like receptors. Blood 115: 1166 1174.
47. Cai G, Kastelein RA, Hunter CA, (1999) IL-10 enhances NK cell proliferation, cytotoxicity and production of IFN-gamma when combined with IL-18. Eur J Immunol 29: 2658 2665.
48. Mocellin S, Panelli M, Wang E, Rossi CR, Pilati P, (2004) IL-10 stimulatory effects on human NK cells explored by gene profile analysis. Genes Immun 5: 621 630.
49. Walter J, Ghosh MK, Kuhn L, Semrau K, Sinkala M, (2009) High concentrations of interleukin 15 in breast milk are associated with protection against postnatal HIV transmission. J Infect Dis 200: 1498 1502.
50. Chatterjee A, Rathore A, Sivarama P, Yamamoto N, Dhole TN, (2009) Genetic association of IL-10 gene promoter polymorphism and HIV-1 infection in North Indians. J Clin Immunol 29: 71 77.
51. Oleksyk TK, Shrestha S, Truelove AL, Goedert JJ, Donfield SM, (2009) Extended IL10 haplotypes and their association with HIV progression to AIDS. Genes Immun 10: 309 322.
52. Stacey AR, Norris PJ, Qin L, Haygreen EA, Taylor E, (2009) Induction of a striking systemic cytokine cascade prior to peak viremia in acute human immunodeficiency virus type 1 infection, in contrast to more modest and delayed responses in acute hepatitis B and C virus infections. J Virol 83: 3719 3733.
53. DeBlaker-Hohe DF, Yamauchi A, Yu CR, Horvath-Arcidiacono JA, Bloom ET, (1995) IL-12 synergizes with IL-2 to induce lymphokine-activated cytotoxicity and perforin and granzyme gene expression in fresh human NK cells. Cell Immunol 165: 33 43.
54. Peppa D, Micco L, Javaid A, Kennedy PT, Schurich A, (2010) Blockade of immunosuppressive cytokines restores NK cell antiviral function in chronic hepatitis B virus infection. PLoS Pathog 6: e1001227.
55. Mueller YM, Do DH, Altork SR, Artlett CM, Gracely EJ, (2008) IL-15 treatment during acute simian immunodeficiency virus (SIV) infection increases viral set point and accelerates disease progression despite the induction of stronger SIV-specific CD8+ T cell responses. J Immunol 180: 350 360.
56. Rosenblum IY, Johnson RC, Schmahai TJ, (2002) Preclinical safety evaluation of recombinant human interleukin-10. Regul Toxicol Pharmacol 35: 56 71.
57. Boyer JD, Robinson TM, Kutzler MA, Vansant G, Hokey DA, (2007) Protection against simian/human immunodeficiency virus (SHIV) 89.6P in macaques after coimmunization with SHIV antigen and IL-15 plasmid. Proc Natl Acad Sci U S A 104: 18648 18653.